[<sup>68</sup>Ga]Ga‑LNC1007 PET/CT in the evaluation of renal cell carcinoma: comparison with 2-[<sup>18</sup>F]FDG/[<sup>68</sup>Ga]Ga-PSMA PET/CT.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 37728667.
- Also identified by DOI 10.1007/s00259-023-06436-5.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To compare the potential efficiency of [<sup>68</sup>Ga]Ga-LNC1007 with 2-[<sup>18</sup>F]FDG/[<sup>68</sup>Ga]Ga-PSMA PET/CT for detecting renal cell carcinoma (RCC) and to explore parameters derived from [<sup>68</sup>Ga]Ga-LNC1007 PET/CT for discriminating pathological characteristics in RCC. Twenty-five RCC patients confirmed by pathology were enrolled in this prospective study. The maximum standardized uptake value (SUV<sub>max</sub>), mean SUV (SUV<sub>mean</sub>), gross tumor volume (GTV) and total lesion-tracer (TL-tracer) of lesions were calculated from the corresponding PET/CT images. Pathological characteristics included World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade and adverse pathological features (tumor necrosis or sarcomatoid or rhabdoid feature). [<sup>68</sup>Ga]Ga-LNC1007 PET/CT showed a higher detection rate for primary lesions than 2-[<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-PSMA (LNC1007 vs. FDG: 13/17 vs. 4/17, P = 0.005; LNC1007 vs. PSMA: 9/11 vs. 6/11, P = 0.361). [<sup>68</sup>Ga]Ga-LNC1007 PET/CT showed higher SUV<sub>max</sub> (6.6 vs. 3.7, P = 0.005), SUV<sub>mean</sub> (4.1 vs. 2.3, P = 0.001) and TBR (2.6 vs. 1.7, P = 0.011) compared with 2-[<sup>18</sup>F]FDG PET/CT, and it also showed higher TBR (2.9 vs. 0.5, P = 0.003), TBR-delay (2.8 vs. 0.3, P = 0.003), GTV (84.1 vs. 42.9, P = 0.003) and TL-tracer (442.7 vs. 235.8, P = 0.008) compared with [<sup>68</sup>Ga]Ga-PSMA PET/CT. SUV<sub>max</sub> and TBR derived from [<sup>68</sup>Ga]Ga-LNC1007 PET/CT could effectively differentiate WHO/ISUP grade (3-4 vs. 1-2) and adverse pathological features (positive vs. negative) (SUV<sub>max</sub>: AUC 0.81, P = 0.04; AUC 0.80, P = 0.033; TBR: AUC 0.84, P = 0.026; AUC 0.85, P = 0.014). The SUV<sub>max</sub> was positively correlated with the FAP expression, integrin α<sub>v</sub>β<sub>3</sub> expression and the total expression of FAP and integrin α<sub>v</sub>β<sub>3</sub> (r = 0.577, P = 0.006, r = 0.701, P < 0.001, and r = 0.702, P < 0.001, respectively). [<sup>68</sup>Ga]Ga-LNC1007 is a promising tracer for RCC imaging and can effectively identify aggressive pathological characteristics of RCC.
Medical subject headings
- Carcinoma, Renal Cell
- Kidney Neoplasms